|
92
|
281
|
4b6lA |
Discovery of oral polo-like kinase (plk) inhibitors with enhanced selectivity profile using residue targeted drug design |
|
85
|
307
|
4bdiA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
146
|
468
|
4aztA |
Co-crystal structure of wbdd and kinase inhibitor ly294002. |
|
112
|
337
|
4axaA |
Structure of pka-pkb chimera complexed with (1s)-2-amino-1-(4- chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol |
|
100
|
347
|
4b99A |
Crystal structure of mapk7 (erk5) with inhibitor |
|
81
|
271
|
4bhnA |
Crystal structures of ask1-inhibitor complexes |
|
95
|
350
|
4b7tA |
Glycogen synthase kinase 3 beta complexed with axin peptide and leucettine l4 |
|
84
|
321
|
4bchA |
Structure of cdk9 in complex with cyclin t and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
148
|
470
|
4azvA |
Co-crystal structure of wbdd and kinase inhibitor gw435821x. |
|
89
|
304
|
4bdgA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
110
|
357
|
4awiA |
Human jnk1alpha kinase with 4-phenyl-7-azaindole ikk2 inhibitor. |
|
78
|
293
|
4bc6A |
Crystal structure of human serine threonine kinase-10 bound to novel bosutinib isoform 1, previously thought to be bosutinib |
|
81
|
298
|
4bghA |
Crystal structure of cdk2 in complex with pan-cdk inhibitor |
|
91
|
296
|
4bggA |
Crystal structure of the acvr1 kinase in complex with ldn-213844 |
|
87
|
303
|
4bdhA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
141
|
445
|
4azwA |
Crystal structure of monomeric wbdd. |
|
89
|
304
|
4bdeA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
83
|
321
|
4bcjA |
Structure of cdk9 in complex with cyclin t and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
77
|
293
|
4aw1A |
Human pdk1 kinase domain in complex with allosteric compound ps210 bound to the pif-pocket |
|
84
|
271
|
4bicA |
Crystal structures of ask1-inhibitor complexes |
|
97
|
299
|
4at3A |
Crystal structure of trkb kinase domain in complex with cpd5n |
|
118
|
350
|
4azeA |
Human dyrk1a in complex with leucettine l41 |
|
152
|
470
|
4azsA |
High resolution (2.2 a) crystal structure of wbdd. |
|
80
|
269
|
4bf2A |
Crystal structures of ask1-inhibitor complexes |
|
139
|
416
|
4aw2A |
Crystal structure of cdc42 binding protein kinase alpha (mrck alpha) |
|
85
|
321
|
4bcfA |
Structure of cdk9 in complex with cyclin t and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
99
|
299
|
4at5A |
Crystal structure of trkb kinase domain in complex with gw2580 |
|
95
|
299
|
4aszA |
Crystal structure of apo trkb kinase domain |
|
147
|
470
|
4ax8A |
Medium resolution structure of the bifunctional kinase- methyltransferase wbdd |
|
82
|
322
|
4bciA |
Structure of cdk9 in complex with cyclin t and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
76
|
266
|
4b0gA |
Complex of aurora-a bound to an imidazopyridine-based inhibitor |
|
85
|
303
|
4bdjA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
79
|
285
|
4aw0A |
Human pdk1 kinase domain in complex with allosteric compound ps182 bound to the pif-pocket |
|
86
|
304
|
4bdaA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
106
|
331
|
4bkyA |
Crystal structure of unphosphorylated maternal embryonic leucine zipper kinase (melk) in complex with pyrrolopyrazole inhibitor |
|
78
|
291
|
4auaA |
Liganded x-ray crystal structure of cyclin dependent kinase 6 (cdk6) |
|
87
|
299
|
4bcpA |
Structure of cdk2 in complex with cyclin a and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
95
|
330
|
4bfmA |
The crystal structure of mouse pk38 |
|
91
|
304
|
4a9tA |
Crystal structure of human chk2 in complex with benzimidazole carboxamide inhibitor |
|
77
|
277
|
4a4xA |
Nek2-ede bound to cct248662 |
|
87
|
282
|
4an3A |
Crystal structures of human mek1 with carboxamide-based allosteric inhibitor xl518 (gdc-0973), or related analogs. |
|
93
|
286
|
3zzeA |
Crystal structure of c-met kinase domain in complex with n'-((3z)-4- chloro-7-methyl-2-oxo-1,2-dihydro-3h-indol-3-ylidene)-2-(4- hydroxyphenyl)propanohydrazide |
|
113
|
359
|
3zuvA |
Crystal structure of a designed selected ankyrin repeat protein in complex with the phosphorylated map kinase erk2 |
|
104
|
349
|
4a9yA |
P38alpha map kinase bound to cmpd 8 |
|
113
|
328
|
4anmA |
Complex of ck2 with a cdc7 inhibitor |
|
54
|
176
|
4annA |
Crystal structure staphylococcus aureus essb cytoplasmic fragment |
|
72
|
270
|
3zxtA |
Dimeric structure of dapk-1 catalytic domain in complex with amppcp- mg |
|
90
|
310
|
3zuuA |
The structure of ost1 (d160a, s175d) kinase in complex with gold |
|
78
|
277
|
4agwA |
Discovery of a small molecule type ii inhibitor of wild-type and gatekeeper mutants of bcr-abl, pdgfralpha, kit, and src kinases |
|
102
|
344
|
3zu7A |
Crystal structure of a designed selected ankyrin repeat protein in complex with the map kinase erk2 |
